Logo image
A novel de novo CAPN5 mutation in a patient with inflammatory vitreoretinopathy, hearing loss, and developmental delay
Journal article   Open access   Peer reviewed

A novel de novo CAPN5 mutation in a patient with inflammatory vitreoretinopathy, hearing loss, and developmental delay

Gabriel Velez, Alexander G Bassuk, Kellie A Schaefer, Brian Brooks, Lokesh Gakhar, MaryAnn Mahajan, Philip Kahn, Stephen H Tsang, Polly J Ferguson and Vinit B Mahajan
Cold Spring Harbor molecular case studies, Vol.4(3), p.a002519
06/2018
DOI: 10.1101/mcs.a002519
PMCID: PMC5983175
PMID: 29472286
url
https://doi.org/10.1101/mcs.a002519View
Published (Version of record) Open Access

Abstract

Mutations that activate the protease calpain-5 ( cause a nonsyndromic adult-onset autoinflammatory eye disease characterized by uveitis, altered synaptic signaling, retinal degeneration, neovascularization, and intraocular fibrosis. We describe a pediatric patient with severe inflammatory vitreoretinopathy accompanied by hearing loss and developmental delay associated with a novel, de novo missense mutation (c.865C>T, p.Arg289Trp) that shows greater hyperactivation of the calpain protease, indicating a genotype-phenotype correlation that links mutation severity to proteolytic activity and the possibility of earlier onset syndromic disease with auditory and neurological abnormalities.
Electroencephalography Phenotype Mutation Amino Acid Sequence Hearing Loss - diagnosis Genetic Association Studies Humans Child, Preschool Models, Molecular Vitreoretinopathy, Proliferative - diagnosis Genotype Male Developmental Disabilities - genetics Calpain - genetics Calpain - chemistry Whole Exome Sequencing Hearing Loss - genetics Vitreoretinopathy, Proliferative - genetics Pedigree Alleles Protein Conformation Developmental Disabilities - diagnosis

Details

Logo image